Companies spend millions developing logos to represent a brand. Some of them have hidden meanings steeped in the history and ...

Johnson & Johnson and Legend Biotech’s BCMA-targeted CAR-T therapy Carvykti has been approved by the FDA to treat patients with multiple myeloma after at least one prior therapy. The decision ...

The study – which tested Carvykti in patients with one to three lines of prior therapy – gives J&J an opportunity to leapfrog Bristol-Myers Squibb and 2Seventy bio's rival BCMA CAR-T therapy ...

The playoff hopes of both the Detroit Red Wings and the Utah Hockey Club are fading fast entering their game on Monday night in Salt Lake City. The Red The Red Wings were right in the playoff race ...

Legend Biotech Corp (LEGN) reports a 110% increase in CARVYKTI sales, outlines expansion strategies, and anticipates profitability by 2026. Although the revenue and EPS for Legend Biotech (LEGN ...